Skip to content

Nicotinic Acid, Nicotinamide, and Nicotinamide Riboside: A Molecular Evaluation of NAD+ Precursor Vitamins in Human Nutrition

Bogan KL, Brenner C | Annual Review of Nutrition | 2008 | Evidence: moderate

Plain-language summary

Published 2008 in Annual Review of Nutrition, this work by Bogan KL and collaborators tackles a specific question within nr-focused NMN/NAD+ research.

Key findings reported by the authors

  • NR positioned as vitamin
  • Bioavailability mechanisms reviewed
  • Therapeutic potential framework

What this means for Malaysian buyers

For readers in Malaysia weighing whether to start or continue NMN supplementation, this paper sits at the moderate end of the evidence spectrum. Moderate-tier evidence usually means a small human trial or a well-designed mouse study; helpful for hypothesis-building but not for hard recommendations. Findings here are most directly relevant to nr decisions, with secondary relevance to vitamin and review. Our editorial methodology weights human placebo-controlled trials above mouse mechanistic work above review articles.

← Back to research index